- Home
- CUE vs SOTK Comparison
CUE vs SOTK Comparison
Compare CUE & SOTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- SOTK
- Stock Information
- Founded
- CUE 2014
- SOTK 1975
- Country
- CUE United States
- SOTK United States
- Employees
- CUE N/A
- SOTK N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- SOTK Industrial Machinery/Components
- Sector
- CUE Health Care
- SOTK Technology
- Exchange
- CUE Nasdaq
- SOTK Nasdaq
- Market Cap
- CUE 52.8M
- SOTK 58.5M
- IPO Year
- CUE 2018
- SOTK 1987
- Fundamental
- Price
- CUE $0.70
- SOTK $3.69
- Analyst Decision
- CUE Strong Buy
- SOTK Hold
- Analyst Count
- CUE 3
- SOTK 1
- Target Price
- CUE $3.00
- SOTK N/A
- AVG Volume (30 Days)
- CUE 318.8K
- SOTK 5.5K
- Earning Date
- CUE 08-13-2025
- SOTK 07-10-2025
- Dividend Yield
- CUE N/A
- SOTK N/A
- EPS Growth
- CUE N/A
- SOTK N/A
- EPS
- CUE N/A
- SOTK 0.09
- Revenue
- CUE $7,991,000.00
- SOTK $20,606,116.00
- Revenue This Year
- CUE N/A
- SOTK N/A
- Revenue Next Year
- CUE $23.84
- SOTK $9.53
- P/E Ratio
- CUE N/A
- SOTK $40.86
- Revenue Growth
- CUE 13.83
- SOTK N/A
- 52 Week Low
- CUE $0.45
- SOTK $3.50
- 52 Week High
- CUE $1.99
- SOTK $6.05
- Technical
- Relative Strength Index (RSI)
- CUE 48.28
- SOTK 42.75
- Support Level
- CUE $0.71
- SOTK $3.63
- Resistance Level
- CUE $0.83
- SOTK $3.82
- Average True Range (ATR)
- CUE 0.07
- SOTK 0.12
- MACD
- CUE 0.00
- SOTK -0.00
- Stochastic Oscillator
- CUE 22.22
- SOTK 0.00
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About SOTK Sono-Tek Corporation
Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.